AbbVie’s popular arthritis drug Humira is a powerhouse, producing $14 billion in annual sales to make up 60 percent of the drugmaker’s revenue. However, generic versions of the drug are around the ...
Humira exclusivity has ended AbbVie Most Recent 10Q An excellent 2023 piece from Healio describes just how big of a deal Humira is: In 2021, Humira — the blockbuster biologic that has for years been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results